About SignalRX Pharmaceuticals
SignalRX Pharmaceuticals is a private company based in Cumming, Georgia. It has reported $250,000 raised in one offering on Form D since May 2023. Its chief executive is Matthew Williams.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2022 | May 3, 2023 | $250,000of $485K target | 2 | $125K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SignalRX Pharmaceuticals's Form D filed May 3, 2023.
GM
Guillermo Morales
Director
JW
Joel Wernick
Director
MW
Matthew Williams
Director and Chief Executive Officer